African-Americans and Indigenous Peoples Have Increased Burden of Diseases of the Exocrine Pancreas: A Systematic Review and Meta-Analysis
- 98 Downloads
Ethnic health disparity is a well-acknowledged issue in many disease settings, but not diseases of the exocrine pancreas. A systematic review and meta-analysis was conducted to explore the race- and ethnicity-specific burden of diseases of the exocrine pancreas. Studies that compared health-related endpoints between two or more ethnicities were eligible for inclusion. Proportion meta-analyses were conducted to compare burden between groups. A total of 42 studies (24 on pancreatic cancer, 17 on pancreatitis, and one on pancreatic cyst) were included in the systematic review, of which 19 studies were suitable for meta-analyses. The incidence of pancreatic cancer was 1.4-fold higher among African–Americans, while the incidence of acute pancreatitis was 4.8-fold higher among an indigenous population (New Zealand Māori) compared with Caucasians. The prevalence of post-pancreatitis diabetes mellitus was up to 3.0-fold higher among certain ethnicities, including Asians, Pacific Islanders, and indigenous populations compared with Caucasians. The burden of diseases of the exocrine pancreas differs between ethnicities, with African-Americans and certain indigenous populations being at the greatest risk of developing these diseases. Development of race- and ethnicity-specific screening as well as protocols for lifestyle modifications may need to be considered with a view to reducing the disparities in burden of diseases of the exocrine pancreas.
KeywordsHealth disparity Pancreatic cancer Pancreatitis Post-pancreatitis diabetes mellitus
This study was part of the Clinical and epidemiological inveStigations in Metabolism, nutrition, and pancreatic diseaseS (COSMOS) program. COSMOS is supported in part by the Auckland Medical Research Foundation (Grant 1116021 to Associate Professor Max Petrov), which played no role in the study design; collection, analysis, or interpretation of data; or writing of the manuscript.
MSP and AC were involved in conception and design. AC and EKW were involved in study identification, screening, and assessment for inclusion. AC was involved in statistical analysis. AC, EKW, and MSP were involved in drafting of the article and critical revision of content.
Compliance with ethical standards
Conflict of interest
The authors declares that they have no conflict of interest.
- 21.Wells G, Shea B, O’connell D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Health Institute; (1996–2006).Google Scholar
- 22.McPheeters ML, Kripalani S, Peterson NB, et al. Closing the gap: revisiting the state of science (vol. 3: quality improvement interventions to address health disparities). Evid Rep Technol Assess. 2012;208:1–475.Google Scholar
- 23.Arnold LD, Patel AV, Yan Y, et al. Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity? Cancer Epidemiol Biomark Prev. 2009;18:2397–2405.Google Scholar
- 26.Eldridge RC, Gapstur SM, Newton CC, et al. Jewish ethnicity and pancreatic cancer mortality in a large U.S. cohort. Cancer Epidemiol Biomark Prev. 2011;20:691–698.Google Scholar
- 28.Fesinmeyer MD, Austin MA, Li CI, et al. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomark Prev. 2005;14:1766–1773.Google Scholar
- 35.Saif MW, Sviglin H, Carpenter M. Impact of ethnicity on outcome in pancreatic carcinoma. JOP. 2005;6:264–54.Google Scholar
- 41.Zell JA, Rhee JM, Ziogas A, et al. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomark Prev. 2007;16:546–552.Google Scholar
- 53.Kandasami P, Harunarashid H, Kaur H. Acute pancreatitis in a multi-ethnic population. Singap Med J. 2002;43:284–288.Google Scholar
- 58.Laffan TA, Horton KM, Klein AP, et al. Prevalence of unsuspected pancreatic cysts on MDCT. Am J Roentgenol. 2008;191:802–807.Google Scholar
- 60.Mehta KM, Yeo GW. Systematic review of dementia prevalence and incidence in United States race/ethnic populations. Alzheimer’s Dement. 2017;13:72–83.Google Scholar
- 66.Grover S, Syngal S. Hereditary pancreatic cancer. Gastroenterology. 2010;139:1076–1080-2.Google Scholar
- 68.Petrov MS. Harnessing analytic morphomics for early detection of pancreatic cancer. Pancreas. 2018;47:1051–1054.Google Scholar
- 70.WHO|Health of indigenous peoples. WHO [Internet]. 2016 [cited 2017 Nov 9]; Available from: http://www.who.int/mediacentre/factsheets/fs326/en/.
- 74.Maclennan B, Kypri K, Connor J, et al. New Zealand’s new alcohol laws: protocol for a mixed-methods evaluation. BMC Public Health. 2015;16:29.Google Scholar
- 75.Singh RG, Pendharkar SA, Cervantes A, et al. Abdominal obesity and insulin resistance after an episode of acute pancreatitis. Dig Liver Dis. 2018; [Epub ahead of print].Google Scholar
- 78.Cervantes A, Singh RG, Pendharkar SA, Bharmal SH, Petrov MS. Profile of gut hormones, pancreatic hormones and pro-inflammatory cytokines in New Zealand Maori. Gastroenterol Res. 2018;11:280–289.Google Scholar
- 80.Singh RG, Nguyen NN, DeSouza SV, Pendharkar SA, Petrov MS. Comprehensive analysis of body composition and insulin traits associated with intra-pancreatic fat deposition in health and new-onset prediabetes/diabetes after acute pancreatitis. Diabetes Obes Metab. 2018. https://doi.org/10.1111/dom.13523.CrossRefPubMedGoogle Scholar
- 83.Marriott L, Sim D. Indicators of inequality for Maori and Pacific people. J N Z Stud. 2015;20:24.Google Scholar